Abivax SA
ABVXUnited States
9 filed reports · 307 financial concepts · 2 media appearances
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
| Figure | Latest fiscal year | Latest quarter |
|---|---|---|
| Revenue | €5.6MFY2025 · to Dec 31, 2025−32.1% from €8.25M20-F | €644KQ1 FY2026 · to Mar 31, 2026−25.0% from €859K6-K |
| Net income | -€336MFY2025 · to Dec 31, 2025a year earlier: -€176M20-F | -€117MQ2 FY2026 · to Jun 30, 2026a year earlier: -€48.4M6-K |
| Operating income | -€246MFY2025 · to Dec 31, 2025a year earlier: -€173M20-F | -€84.1MQ2 FY2026 · to Jun 30, 2026a year earlier: -€46.5M6-K |
Filed reports
9 reports · Dec 2023 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 20 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Interim · 6-KSEC EDGAR | 5 | 1,426 | Mar 2025 to Jun 2026 |
| Annual · 20-FSEC EDGAR | 4 | 1,397 | Dec 2023 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Sep 21, 2026 | 57 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | May 22, 2026 | 480 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 23, 2026 | 20 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 23, 2026 | 1,029 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Dec 15, 2025 | 361 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Sep 8, 2025 | 320 | Open |
| FY2025 Q1 | 6-K | Mar 31, 2025 | Jun 2, 2025 | 208 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Mar 24, 2025 | 336 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Apr 5, 2024 | 12 | Open |
Financial data
307 concepts · 2,823 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial306 concepts · 2,809 facts · Sep 2022 to Jun 2026
- Advances related to CRO contracts24 · Dec 2022 to Mar 2026
- Convertible loan notes22 · Dec 2022 to Dec 2025
- Other19 · Dec 2022 to Dec 2025
- EPS (Basic)16 · Dec 2022 to Jun 2026
- EPS (Diluted)16 · Dec 2022 to Jun 2026
- Interest Expense16 · Dec 2022 to Jun 2026
- Operating Income16 · Dec 2022 to Jun 2026
- Par value per share16 · Sep 2022 to Mar 2026
- R&D Expense16 · Dec 2022 to Jun 2026
- Cash and cash equivalents15 · Dec 2022 to Mar 2026
- Derivative financial liabilities (IFRS)15 · Dec 2022 to Mar 2026
- Equity15 · Dec 2022 to Mar 2026
- Income Tax Expense (Benefit)15 · Dec 2022 to Jun 2026
- Intangible assets other than goodwill15 · Dec 2022 to Mar 2026
- Lease liabilities15 · Dec 2022 to Mar 2026
- Liabilities arising from financing activities15 · Dec 2022 to Mar 2026
- Net Income15 · Dec 2022 to Jun 2026
- Number of shares issued15 · Dec 2022 to Mar 2026
- Pretax Income15 · Dec 2022 to Jun 2026
- Property plant and equipment including rightofuse assets15 · Dec 2022 to Mar 2026
- Research tax credit ("CIR")15 · Dec 2022 to Mar 2026
- Other receivables and assets14 · Dec 2022 to Mar 2026
- Adjustments for decrease increase in trade and other receivables13 · Dec 2022 to Mar 2026
- Adjustments for depreciation and amortisation expense13 · Dec 2022 to Mar 2026
Geography1 concept · 14 facts · Dec 2022 to Mar 2026
- Average number of employees14 · Dec 2022 to Mar 2026
Segments
14 factsFigures broken down by business line, region, product or another axis the company reports on.
Geographical areas2 members · 14 facts
- FR7 · Dec 2022 to Mar 2026
- US7 · Dec 2022 to Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary39 claims from 2 reports · Dec 2024 to Dec 2025
- Risk-factor changes17 claims from 1 report · Dec 2025
- Risk factors170 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
2 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances1 · Nov 2023
- Podcasts1 · Jan 2026
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Abivax SA (ABVX) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 12, 2026) and refreshed every few hours.